Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share (ANRO).
- Disclosed ownership: 8.9%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 8.9% ownership in Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share (ANRO) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 6.8% | 2,156,497 | 0 | 2,156,497 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 6.8% | 2,156,497 | 0 | 2,156,497 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Biotech Private Investments, LLC | 2.1% | 667,778 | 0 | 667,778 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| Differentiated Ventures Investments, LLC | 2.1% | 667,778 | 0 | 667,778 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| 72 Investment Holdings, LLC | 2.1% | 667,778 | 0 | 667,778 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 8.9% | 2,824,275 | 0 | 2,824,275 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |